Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56K Sell
149
-306
-67% -$12.8K ﹤0.01% 859
2026
Q1
$22.3K Buy
455
+129
+40% +$6.77K ﹤0.01% 499
2025
Q4
$17.3K Buy
326
+30
+10% +$1.75K ﹤0.01% 517
2025
Q3
$18.2K Buy
+296
New +$17K ﹤0.01% 514
2024
Q3
Sell
-325
Closed -$11.5K 760
2024
Q2
$11.5K Buy
325
+238
+274% +$7.66K ﹤0.01% 661
2024
Q1
$2.88K Buy
+87
New +$3.24K ﹤0.01% 822

Other funds holding CALX

Crewe Advisors's CALX Position: Q2 2026 in Review

Crewe Advisors reduced its Calix (CALX) stake by 67% in Q2 2026, selling an estimated $12.8K and leaving 149 shares worth $5.56K. The position accounts for ﹤0.01% of the portfolio, ranked #859.

Crewe Advisors first reported a position in CALX in Q1 2024 and has held it in 6 quarters since. The position peaked at $22.3K in Q1 2026. 287 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Crewe Advisors held 149 shares of Calix worth $5.56K as of Q2 2026.
  • Crewe Advisors sold 306 Calix shares in Q2 2026, an estimated $12.8K.
  • Calix made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #859 holding.
  • Crewe Advisors first reported a position in Calix in Q1 2024 and has held it in 6 quarters since.
  • Crewe Advisors's Calix position peaked at $22.3K in Q1 2026.
  • 287 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.